nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxazosin—ADRA1D—polycystic ovary syndrome	0.349	0.412	CbGaD
Doxazosin—ADRA1B—polycystic ovary syndrome	0.298	0.351	CbGaD
Doxazosin—ADRA1A—polycystic ovary syndrome	0.2	0.237	CbGaD
Doxazosin—Gastrointestinal tract irritation—Metformin—polycystic ovary syndrome	0.00327	0.086	CcSEcCtD
Doxazosin—CYP2C19—urine—polycystic ovary syndrome	0.00183	0.131	CbGeAlD
Doxazosin—Nail disorder—Metformin—polycystic ovary syndrome	0.0018	0.0474	CcSEcCtD
Doxazosin—Fungal infection—Metformin—polycystic ovary syndrome	0.00151	0.0398	CcSEcCtD
Doxazosin—Rigors—Metformin—polycystic ovary syndrome	0.00143	0.0376	CcSEcCtD
Doxazosin—Alfuzosin—ADRA1D—polycystic ovary syndrome	0.00138	0.162	CrCbGaD
Doxazosin—KCNH6—uterus—polycystic ovary syndrome	0.00124	0.0885	CbGeAlD
Doxazosin—Terazosin—ADRA1D—polycystic ovary syndrome	0.00121	0.141	CrCbGaD
Doxazosin—Alfuzosin—ADRA1B—polycystic ovary syndrome	0.00118	0.138	CrCbGaD
Doxazosin—CYP2D6—urine—polycystic ovary syndrome	0.00106	0.0761	CbGeAlD
Doxazosin—Terazosin—ADRA1B—polycystic ovary syndrome	0.00103	0.121	CrCbGaD
Doxazosin—Ear pain—Metformin—polycystic ovary syndrome	0.000995	0.0261	CcSEcCtD
Doxazosin—Migraine—Metformin—polycystic ovary syndrome	0.000835	0.022	CcSEcCtD
Doxazosin—Prazosin—ADRA1D—polycystic ovary syndrome	0.00083	0.0969	CrCbGaD
Doxazosin—Alfuzosin—ADRA1A—polycystic ovary syndrome	0.000795	0.0929	CrCbGaD
Doxazosin—Dehydration—Metformin—polycystic ovary syndrome	0.000789	0.0207	CcSEcCtD
Doxazosin—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.000783	0.0206	CcSEcCtD
Doxazosin—Cramp muscle—Metformin—polycystic ovary syndrome	0.000764	0.0201	CcSEcCtD
Doxazosin—Abdominal distension—Metformin—polycystic ovary syndrome	0.000738	0.0194	CcSEcCtD
Doxazosin—Angina pectoris—Metformin—polycystic ovary syndrome	0.000714	0.0188	CcSEcCtD
Doxazosin—Sweating increased—Metformin—polycystic ovary syndrome	0.000714	0.0188	CcSEcCtD
Doxazosin—Prazosin—ADRA1B—polycystic ovary syndrome	0.000708	0.0827	CrCbGaD
Doxazosin—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.000703	0.0185	CcSEcCtD
Doxazosin—Terazosin—ADRA1A—polycystic ovary syndrome	0.000695	0.0812	CrCbGaD
Doxazosin—Neutropenia—Metformin—polycystic ovary syndrome	0.000686	0.018	CcSEcCtD
Doxazosin—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.000682	0.0179	CcSEcCtD
Doxazosin—Drowsiness—Metformin—polycystic ovary syndrome	0.000654	0.0172	CcSEcCtD
Doxazosin—ORM1—endometrium—polycystic ovary syndrome	0.000612	0.0438	CbGeAlD
Doxazosin—Bradycardia—Metformin—polycystic ovary syndrome	0.000598	0.0157	CcSEcCtD
Doxazosin—Rhinitis—Metformin—polycystic ovary syndrome	0.000589	0.0155	CcSEcCtD
Doxazosin—Hepatitis—Metformin—polycystic ovary syndrome	0.000587	0.0154	CcSEcCtD
Doxazosin—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.000584	0.0154	CcSEcCtD
Doxazosin—Eye disorder—Metformin—polycystic ovary syndrome	0.000549	0.0144	CcSEcCtD
Doxazosin—Flushing—Metformin—polycystic ovary syndrome	0.000545	0.0143	CcSEcCtD
Doxazosin—Chills—Metformin—polycystic ovary syndrome	0.000527	0.0138	CcSEcCtD
Doxazosin—ADRA1D—endocrine gland—polycystic ovary syndrome	0.000521	0.0373	CbGeAlD
Doxazosin—Malnutrition—Metformin—polycystic ovary syndrome	0.000511	0.0134	CcSEcCtD
Doxazosin—Flatulence—Metformin—polycystic ovary syndrome	0.000504	0.0132	CcSEcCtD
Doxazosin—Dysgeusia—Metformin—polycystic ovary syndrome	0.0005	0.0132	CcSEcCtD
Doxazosin—Muscle spasms—Metformin—polycystic ovary syndrome	0.000491	0.0129	CcSEcCtD
Doxazosin—Vision blurred—Metformin—polycystic ovary syndrome	0.000482	0.0127	CcSEcCtD
Doxazosin—Tremor—Metformin—polycystic ovary syndrome	0.000479	0.0126	CcSEcCtD
Doxazosin—Prazosin—ADRA1A—polycystic ovary syndrome	0.000477	0.0557	CrCbGaD
Doxazosin—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000474	0.0125	CcSEcCtD
Doxazosin—Malaise—Metformin—polycystic ovary syndrome	0.000461	0.0121	CcSEcCtD
Doxazosin—Syncope—Metformin—polycystic ovary syndrome	0.000458	0.012	CcSEcCtD
Doxazosin—Palpitations—Metformin—polycystic ovary syndrome	0.000452	0.0119	CcSEcCtD
Doxazosin—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000449	0.0118	CcSEcCtD
Doxazosin—Hypertension—Metformin—polycystic ovary syndrome	0.000441	0.0116	CcSEcCtD
Doxazosin—Chest pain—Metformin—polycystic ovary syndrome	0.000435	0.0114	CcSEcCtD
Doxazosin—Myalgia—Metformin—polycystic ovary syndrome	0.000435	0.0114	CcSEcCtD
Doxazosin—Discomfort—Metformin—polycystic ovary syndrome	0.00043	0.0113	CcSEcCtD
Doxazosin—ORM1—endocrine gland—polycystic ovary syndrome	0.000429	0.0307	CbGeAlD
Doxazosin—Oedema—Metformin—polycystic ovary syndrome	0.000417	0.011	CcSEcCtD
Doxazosin—Infection—Metformin—polycystic ovary syndrome	0.000414	0.0109	CcSEcCtD
Doxazosin—KCNH2—endometrium—polycystic ovary syndrome	0.000412	0.0295	CbGeAlD
Doxazosin—Shock—Metformin—polycystic ovary syndrome	0.00041	0.0108	CcSEcCtD
Doxazosin—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000408	0.0107	CcSEcCtD
Doxazosin—Skin disorder—Metformin—polycystic ovary syndrome	0.000405	0.0106	CcSEcCtD
Doxazosin—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000403	0.0106	CcSEcCtD
Doxazosin—Anorexia—Metformin—polycystic ovary syndrome	0.000398	0.0104	CcSEcCtD
Doxazosin—Hypotension—Metformin—polycystic ovary syndrome	0.00039	0.0102	CcSEcCtD
Doxazosin—ADRA1A—adipose tissue—polycystic ovary syndrome	0.000385	0.0275	CbGeAlD
Doxazosin—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00038	0.00999	CcSEcCtD
Doxazosin—KCNH2—uterus—polycystic ovary syndrome	0.00038	0.0272	CbGeAlD
Doxazosin—Paraesthesia—Metformin—polycystic ovary syndrome	0.000375	0.00984	CcSEcCtD
Doxazosin—KCNH2—pituitary gland—polycystic ovary syndrome	0.000373	0.0267	CbGeAlD
Doxazosin—Dyspnoea—Metformin—polycystic ovary syndrome	0.000372	0.00977	CcSEcCtD
Doxazosin—Somnolence—Metformin—polycystic ovary syndrome	0.000371	0.00974	CcSEcCtD
Doxazosin—Dyspepsia—Metformin—polycystic ovary syndrome	0.000367	0.00965	CcSEcCtD
Doxazosin—Decreased appetite—Metformin—polycystic ovary syndrome	0.000363	0.00953	CcSEcCtD
Doxazosin—Fatigue—Metformin—polycystic ovary syndrome	0.00036	0.00945	CcSEcCtD
Doxazosin—Constipation—Metformin—polycystic ovary syndrome	0.000357	0.00937	CcSEcCtD
Doxazosin—ADRA1A—adrenal gland—polycystic ovary syndrome	0.000345	0.0247	CbGeAlD
Doxazosin—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000344	0.00903	CcSEcCtD
Doxazosin—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000341	0.00896	CcSEcCtD
Doxazosin—KCNH2—adrenal gland—polycystic ovary syndrome	0.000333	0.0238	CbGeAlD
Doxazosin—Urticaria—Metformin—polycystic ovary syndrome	0.000331	0.00871	CcSEcCtD
Doxazosin—Abdominal pain—Metformin—polycystic ovary syndrome	0.00033	0.00867	CcSEcCtD
Doxazosin—ADRA2A—endometrium—polycystic ovary syndrome	0.000324	0.0232	CbGeAlD
Doxazosin—CYP2C19—vagina—polycystic ovary syndrome	0.000324	0.0232	CbGeAlD
Doxazosin—KCNH2—female gonad—polycystic ovary syndrome	0.000311	0.0222	CbGeAlD
Doxazosin—KCNH2—vagina—polycystic ovary syndrome	0.000309	0.0221	CbGeAlD
Doxazosin—CYP2C19—endocrine gland—polycystic ovary syndrome	0.000303	0.0217	CbGeAlD
Doxazosin—Asthenia—Metformin—polycystic ovary syndrome	0.000299	0.00786	CcSEcCtD
Doxazosin—ADRA1A—endocrine gland—polycystic ovary syndrome	0.000299	0.0214	CbGeAlD
Doxazosin—ADRA2A—uterus—polycystic ovary syndrome	0.000299	0.0214	CbGeAlD
Doxazosin—Pruritus—Metformin—polycystic ovary syndrome	0.000295	0.00776	CcSEcCtD
Doxazosin—ADRA2A—pituitary gland—polycystic ovary syndrome	0.000294	0.021	CbGeAlD
Doxazosin—ADRA2A—adipose tissue—polycystic ovary syndrome	0.000292	0.0209	CbGeAlD
Doxazosin—KCNH2—endocrine gland—polycystic ovary syndrome	0.000289	0.0207	CbGeAlD
Doxazosin—Diarrhoea—Metformin—polycystic ovary syndrome	0.000285	0.0075	CcSEcCtD
Doxazosin—Dizziness—Metformin—polycystic ovary syndrome	0.000276	0.00725	CcSEcCtD
Doxazosin—Vomiting—Metformin—polycystic ovary syndrome	0.000265	0.00697	CcSEcCtD
Doxazosin—Rash—Metformin—polycystic ovary syndrome	0.000263	0.00691	CcSEcCtD
Doxazosin—Dermatitis—Metformin—polycystic ovary syndrome	0.000263	0.0069	CcSEcCtD
Doxazosin—ADRA2A—adrenal gland—polycystic ovary syndrome	0.000262	0.0188	CbGeAlD
Doxazosin—Headache—Metformin—polycystic ovary syndrome	0.000261	0.00687	CcSEcCtD
Doxazosin—Nausea—Metformin—polycystic ovary syndrome	0.000248	0.00651	CcSEcCtD
Doxazosin—ABCB1—embryo—polycystic ovary syndrome	0.000247	0.0177	CbGeAlD
Doxazosin—ADRA2A—female gonad—polycystic ovary syndrome	0.000245	0.0175	CbGeAlD
Doxazosin—ADRA2A—vagina—polycystic ovary syndrome	0.000243	0.0174	CbGeAlD
Doxazosin—Prazosin—CYP1A1—polycystic ovary syndrome	0.000243	0.0284	CrCbGaD
Doxazosin—ADRA2A—endocrine gland—polycystic ovary syndrome	0.000227	0.0163	CbGeAlD
Doxazosin—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000202	0.0145	CbGeAlD
Doxazosin—CYP2D6—female gonad—polycystic ovary syndrome	0.000189	0.0136	CbGeAlD
Doxazosin—ABCB1—endometrium—polycystic ovary syndrome	0.000181	0.0129	CbGeAlD
Doxazosin—CYP2D6—endocrine gland—polycystic ovary syndrome	0.000176	0.0126	CbGeAlD
Doxazosin—ABCB1—uterus—polycystic ovary syndrome	0.000167	0.0119	CbGeAlD
Doxazosin—ABCB1—pituitary gland—polycystic ovary syndrome	0.000164	0.0117	CbGeAlD
Doxazosin—ABCB1—adipose tissue—polycystic ovary syndrome	0.000163	0.0117	CbGeAlD
Doxazosin—ABCB1—adrenal gland—polycystic ovary syndrome	0.000146	0.0105	CbGeAlD
Doxazosin—ABCB1—female gonad—polycystic ovary syndrome	0.000136	0.00975	CbGeAlD
Doxazosin—ABCB1—vagina—polycystic ovary syndrome	0.000135	0.0097	CbGeAlD
Doxazosin—ABCB1—endocrine gland—polycystic ovary syndrome	0.000127	0.00907	CbGeAlD
Doxazosin—ADRA1B—Signaling Pathways—MTNR1B—polycystic ovary syndrome	1.53e-05	0.000166	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	1.52e-05	0.000165	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	1.52e-05	0.000165	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—LHB—polycystic ovary syndrome	1.52e-05	0.000165	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—STAR—polycystic ovary syndrome	1.5e-05	0.000163	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	1.5e-05	0.000163	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—FGF18—polycystic ovary syndrome	1.5e-05	0.000163	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.5e-05	0.000163	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—RBP4—polycystic ovary syndrome	1.49e-05	0.000162	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	1.49e-05	0.000161	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—GNRH1—polycystic ovary syndrome	1.48e-05	0.000161	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	1.48e-05	0.000161	CbGpPWpGaD
Doxazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	1.48e-05	0.000161	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.48e-05	0.00016	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—SULT2A1—polycystic ovary syndrome	1.47e-05	0.000159	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—GNAS—polycystic ovary syndrome	1.47e-05	0.000159	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PGR—polycystic ovary syndrome	1.46e-05	0.000159	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—FST—polycystic ovary syndrome	1.44e-05	0.000157	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	1.44e-05	0.000156	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	1.44e-05	0.000156	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	1.43e-05	0.000156	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—ADRB3—polycystic ovary syndrome	1.43e-05	0.000155	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—RRM2—polycystic ovary syndrome	1.42e-05	0.000154	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—SCT—polycystic ovary syndrome	1.42e-05	0.000154	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	1.42e-05	0.000154	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—LHB—polycystic ovary syndrome	1.41e-05	0.000153	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	1.4e-05	0.000152	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—YAP1—polycystic ovary syndrome	1.39e-05	0.000151	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—GNRH1—polycystic ovary syndrome	1.38e-05	0.00015	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	1.37e-05	0.000149	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—YAP1—polycystic ovary syndrome	1.37e-05	0.000149	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—GAB1—polycystic ovary syndrome	1.37e-05	0.000149	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—IGF1—polycystic ovary syndrome	1.36e-05	0.000148	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—AKT2—polycystic ovary syndrome	1.36e-05	0.000148	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—GHRL—polycystic ovary syndrome	1.36e-05	0.000147	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PLAT—polycystic ovary syndrome	1.36e-05	0.000147	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	1.36e-05	0.000147	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	1.34e-05	0.000146	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	1.34e-05	0.000145	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	1.33e-05	0.000145	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—FGF18—polycystic ovary syndrome	1.33e-05	0.000145	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	1.33e-05	0.000145	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—RBP4—polycystic ovary syndrome	1.32e-05	0.000143	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SCT—polycystic ovary syndrome	1.32e-05	0.000143	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—NAMPT—polycystic ovary syndrome	1.32e-05	0.000143	CbGpPWpGaD
Doxazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	1.32e-05	0.000143	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—INSR—polycystic ovary syndrome	1.31e-05	0.000142	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	1.31e-05	0.000142	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.31e-05	0.000142	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	1.3e-05	0.000142	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—GNAS—polycystic ovary syndrome	1.3e-05	0.000141	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—CYP11A1—polycystic ovary syndrome	1.3e-05	0.000141	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—ATF1—polycystic ovary syndrome	1.3e-05	0.000141	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—SERPINE1—polycystic ovary syndrome	1.3e-05	0.000141	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.29e-05	0.000141	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	1.28e-05	0.000139	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.26e-05	0.000137	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	1.26e-05	0.000137	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.26e-05	0.000137	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	1.26e-05	0.000137	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.26e-05	0.000137	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.24e-05	0.000135	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—FGF18—polycystic ovary syndrome	1.24e-05	0.000134	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—YAP1—polycystic ovary syndrome	1.23e-05	0.000134	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—AKR1C3—polycystic ovary syndrome	1.23e-05	0.000133	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—RBP4—polycystic ovary syndrome	1.23e-05	0.000133	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.23e-05	0.000133	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.23e-05	0.000133	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—GAB1—polycystic ovary syndrome	1.22e-05	0.000132	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PGR—polycystic ovary syndrome	1.21e-05	0.000132	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—CYP17A1—polycystic ovary syndrome	1.21e-05	0.000131	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—GNAS—polycystic ovary syndrome	1.21e-05	0.000131	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	1.2e-05	0.000131	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—NGFR—polycystic ovary syndrome	1.2e-05	0.00013	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	1.19e-05	0.00013	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—POMC—polycystic ovary syndrome	1.19e-05	0.000129	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PRL—polycystic ovary syndrome	1.19e-05	0.000129	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	1.17e-05	0.000127	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—LHB—polycystic ovary syndrome	1.17e-05	0.000127	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—INSR—polycystic ovary syndrome	1.16e-05	0.000126	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—YAP1—polycystic ovary syndrome	1.15e-05	0.000124	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.14e-05	0.000124	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	1.14e-05	0.000124	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—GAB1—polycystic ovary syndrome	1.13e-05	0.000123	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	1.13e-05	0.000123	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PLAT—polycystic ovary syndrome	1.13e-05	0.000122	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—GHRL—polycystic ovary syndrome	1.13e-05	0.000122	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.12e-05	0.000122	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.11e-05	0.00012	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	1.1e-05	0.00012	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	1.1e-05	0.000119	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.09e-05	0.000118	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.09e-05	0.000118	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—INSR—polycystic ovary syndrome	1.08e-05	0.000117	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PGR—polycystic ovary syndrome	1.08e-05	0.000117	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—ATF1—polycystic ovary syndrome	1.08e-05	0.000117	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	1.07e-05	0.000117	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.05e-05	0.000114	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—TH—polycystic ovary syndrome	1.05e-05	0.000114	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.04e-05	0.000113	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—GNAS—polycystic ovary syndrome	1.04e-05	0.000113	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	1.04e-05	0.000113	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	1.04e-05	0.000113	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.03e-05	0.000111	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—SLC2A4—polycystic ovary syndrome	1.02e-05	0.00011	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	1.02e-05	0.00011	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.01e-05	0.00011	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	1.01e-05	0.000109	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PLAT—polycystic ovary syndrome	1e-05	0.000109	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—GHRL—polycystic ovary syndrome	1e-05	0.000109	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PGR—polycystic ovary syndrome	1e-05	0.000109	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.93e-06	0.000108	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—NGFR—polycystic ovary syndrome	9.93e-06	0.000108	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—POMC—polycystic ovary syndrome	9.87e-06	0.000107	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PRL—polycystic ovary syndrome	9.84e-06	0.000107	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	9.84e-06	0.000107	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—NRG1—polycystic ovary syndrome	9.75e-06	0.000106	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	9.71e-06	0.000105	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	9.65e-06	0.000105	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—CYP19A1—polycystic ovary syndrome	9.57e-06	0.000104	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	9.57e-06	0.000104	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—ATF1—polycystic ovary syndrome	9.56e-06	0.000104	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—AKT2—polycystic ovary syndrome	9.48e-06	0.000103	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	9.48e-06	0.000103	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—ADRB2—polycystic ovary syndrome	9.33e-06	0.000101	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	9.33e-06	0.000101	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	9.32e-06	0.000101	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PLAT—polycystic ovary syndrome	9.31e-06	0.000101	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—GHRL—polycystic ovary syndrome	9.31e-06	0.000101	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	9.28e-06	0.000101	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	9.28e-06	0.000101	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	9.27e-06	0.000101	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	9.22e-06	0.0001	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	9.15e-06	9.93e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	9.11e-06	9.89e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	9e-06	9.76e-05	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	8.97e-06	9.73e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	8.93e-06	9.7e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—VEGFA—polycystic ovary syndrome	8.91e-06	9.67e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—ATF1—polycystic ovary syndrome	8.88e-06	9.64e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NGFR—polycystic ovary syndrome	8.82e-06	9.57e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—POMC—polycystic ovary syndrome	8.76e-06	9.51e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PRL—polycystic ovary syndrome	8.74e-06	9.49e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	8.7e-06	9.45e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	8.66e-06	9.4e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—GNAS—polycystic ovary syndrome	8.66e-06	9.39e-05	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	8.62e-06	9.35e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	8.58e-06	9.32e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	8.57e-06	9.3e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—GNAS—polycystic ovary syndrome	8.54e-06	9.27e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	8.5e-06	9.22e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	8.48e-06	9.2e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	8.42e-06	9.14e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	8.36e-06	9.08e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IRS2—polycystic ovary syndrome	8.35e-06	9.07e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	8.29e-06	9e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.25e-06	8.95e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NGFR—polycystic ovary syndrome	8.19e-06	8.89e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—LEP—polycystic ovary syndrome	8.17e-06	8.87e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—POMC—polycystic ovary syndrome	8.14e-06	8.84e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—NCOR1—polycystic ovary syndrome	8.14e-06	8.83e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PRL—polycystic ovary syndrome	8.12e-06	8.81e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—NRG1—polycystic ovary syndrome	8.09e-06	8.78e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	8.01e-06	8.69e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	7.88e-06	8.55e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	7.83e-06	8.49e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—CYP1A1—polycystic ovary syndrome	7.72e-06	8.37e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	7.7e-06	8.36e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—GNAS—polycystic ovary syndrome	7.69e-06	8.34e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—TH—polycystic ovary syndrome	7.41e-06	8.05e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	7.32e-06	7.95e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IRS1—polycystic ovary syndrome	7.29e-06	7.91e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—TH—polycystic ovary syndrome	7.24e-06	7.85e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	7.21e-06	7.83e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—MTHFR—polycystic ovary syndrome	7.19e-06	7.81e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NRG1—polycystic ovary syndrome	7.19e-06	7.8e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—GNAS—polycystic ovary syndrome	7.14e-06	7.75e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	7.04e-06	7.64e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—POMC—polycystic ovary syndrome	7.02e-06	7.62e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—INS—polycystic ovary syndrome	6.98e-06	7.58e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IRS2—polycystic ovary syndrome	6.93e-06	7.52e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—TH—polycystic ovary syndrome	6.82e-06	7.4e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	6.81e-06	7.39e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—LEP—polycystic ovary syndrome	6.78e-06	7.36e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	6.78e-06	7.36e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IGF1—polycystic ovary syndrome	6.75e-06	7.33e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—AKT2—polycystic ovary syndrome	6.75e-06	7.33e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NRG1—polycystic ovary syndrome	6.68e-06	7.25e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	6.63e-06	7.2e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	6.62e-06	7.18e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.41e-06	6.96e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	6.24e-06	6.77e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IRS2—polycystic ovary syndrome	6.16e-06	6.68e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	6.05e-06	6.57e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IRS1—polycystic ovary syndrome	6.05e-06	6.57e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—LEP—polycystic ovary syndrome	6.03e-06	6.54e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	5.91e-06	6.41e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PPARG—polycystic ovary syndrome	5.83e-06	6.33e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—POMC—polycystic ovary syndrome	5.83e-06	6.33e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—INS—polycystic ovary syndrome	5.8e-06	6.29e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	5.77e-06	6.26e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—POMC—polycystic ovary syndrome	5.75e-06	6.24e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IRS2—polycystic ovary syndrome	5.72e-06	6.21e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—INS—polycystic ovary syndrome	5.72e-06	6.21e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	5.63e-06	6.11e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IGF1—polycystic ovary syndrome	5.61e-06	6.08e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—AKT2—polycystic ovary syndrome	5.6e-06	6.08e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—LEP—polycystic ovary syndrome	5.6e-06	6.08e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	5.57e-06	6.04e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	5.47e-06	5.93e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IRS1—polycystic ovary syndrome	5.38e-06	5.83e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	5.34e-06	5.79e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.32e-06	5.78e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	5.3e-06	5.76e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—POMC—polycystic ovary syndrome	5.18e-06	5.62e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—IL6—polycystic ovary syndrome	5.17e-06	5.61e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—INS—polycystic ovary syndrome	5.15e-06	5.59e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	5.1e-06	5.53e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	5.03e-06	5.46e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IRS1—polycystic ovary syndrome	4.99e-06	5.42e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IGF1—polycystic ovary syndrome	4.98e-06	5.4e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—AKT2—polycystic ovary syndrome	4.98e-06	5.4e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	4.97e-06	5.4e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—POMC—polycystic ovary syndrome	4.81e-06	5.22e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—INS—polycystic ovary syndrome	4.78e-06	5.19e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.73e-06	5.13e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	4.69e-06	5.09e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IGF1—polycystic ovary syndrome	4.63e-06	5.02e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—AKT2—polycystic ovary syndrome	4.62e-06	5.02e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.41e-06	4.79e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.39e-06	4.77e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—IL6—polycystic ovary syndrome	4.29e-06	4.65e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	4.13e-06	4.48e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	4.08e-06	4.42e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—INS—polycystic ovary syndrome	4.05e-06	4.4e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	4.03e-06	4.38e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—POMC—polycystic ovary syndrome	3.98e-06	4.32e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—INS—polycystic ovary syndrome	3.96e-06	4.29e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—IL6—polycystic ovary syndrome	3.81e-06	4.13e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	3.8e-06	4.12e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	3.75e-06	4.07e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—INS—polycystic ovary syndrome	3.73e-06	4.05e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.66e-06	3.97e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—IL6—polycystic ovary syndrome	3.54e-06	3.84e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.25e-06	3.53e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IL6—polycystic ovary syndrome	3.05e-06	3.31e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.02e-06	3.28e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IL6—polycystic ovary syndrome	2.53e-06	2.75e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IL6—polycystic ovary syndrome	2.25e-06	2.44e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IL6—polycystic ovary syndrome	2.09e-06	2.27e-05	CbGpPWpGaD
